NLRP3 and colitis: This dual action influences macrophage phenotype and reinforces the antioxidant response.98 These findings suggest that the NLRP3 and Nrf2/HO-1 pathways may be involved in TSN’s control of macrophage modification, attenuating DSS-induced colitis.